The French National Research Agency Projects for science

Voir cette page en français


Category :

11/10/2018 Research and Science, Funding opportunities, Conferences and events

Global Security Research: See you at the 12th WISG Symposium!

The French National Research Agency (ANR) will be hosting the 12th edition of the Interdisciplinary Workshop on Global Security (WISG) from 16 to 17 October 2018 in Lyon. The event is organised in partnership with the French Directorate-General for Research and Innovation (DGRI), the French Defence Procurement Agency (DGA) and the French General Secretariat for Defence and National Security (SGDSN). It will offer researchers, businesses and institutional stakeholders a platform to discover the outstanding results of ANR projects and specific activities undertaken by the Agency and its partners, while allowing them to engage with potential partners. Free entry with registration

10/09/2018 Research and Science

The ANR signs the San Francisco Declaration on Research Assessment

On 7 September 2018, the French National Research Agency (ANR) joined research organisations and institutions in signing the San Francisco Declaration on Research Assessment (DORA). The Declaration sets out a series of recommendations to improve research assessment, emphasising the quality of scientific output over the reputation of scientific journals.

04/09/2018 Research and Science

Open Science: the ANR is a Partner of the S cOAlition and Supports the S Plan

As a member of Science Europe, the French National Research Agency (ANR) carries on its Open Science policy by becoming a partner of the cOAlition S.

28/08/2018 Funding opportunities, Research and Science

The ERA-NET NEURON is issuing the 2018 Excellent Paper in Neuroscience Award

The ERA-NET NEURON partner countries are issuing the Excellent Paper in Neuroscience Award to recognize the most remarkable scientific publications published by young researchers between January 1st 2017 and December 31st 2017. The deadline for submission is October 1st 2018.

26/06/2018 Funding opportunities, Research and Science

Antimicrobial resistance: BEAM Alliance recommends ten measures to support innovative SMEs

Selected in the JPI AMR 2016 call for transnational working groups, Beam Alliance represents approximately 50 European SMEs developing innovative products in the field of antimicrobial resistance. In order to support SMEs and their R&D activities, BEAM Alliance recommends ten strategic measures intended for stakeholders (financing agencies, international networks, governments, etc.).

08/12/2017 Research and Science

AFT3, a new target for cancer treatment

Over the course of a cell's life those endure many stresses, some of which result in DNA damage. To have time to repair these lesions, cells inhibit fundamental processes including transcription, a mechanism that allows gene expression. Frédéric Coin and Jean-Marc Egly’s team at the IGBMC showed that the degradation of the AFT3 protein is essential to restart the transcription once the lesions are repaired. This discovery may optimize certain chemotherapies based on the mechanism of stress. These results are published in the journal Molecular Cell on December 7, 2017.

30/11/2017 Research and Science

ForestValue Call 2017 – Networking Webinar – PRESENTATIONS and SUMMARY available!

The ForestValue networking webinar on November 15th 2017 connected over 100 researchers interested in the ForestValue call for proposals.

27/11/2017 Research and Science, Europe & International

A French delegation at the second CREST symposium on quantum technologies in Kyoto

On the occasion of the second CREST symposium on quantum technologies to be held at Kyoto University on December 7 and 8, a French delegation will present the state of research in France in quantum technologies.

24/04/2017 Research and Science, Europe & International

Personalised Medicine : an international Action Plan published

Personalised medicine is an innovative method to treat patients that uses research, data and cutting-edge technology in providing better diagnostics and follow-up. It facilitates more personalised health interventions for citizens and offers tailored therapies and treatments for patients. The full potential of personalised medicine cannot be achieved due to several barriers and challenges. To boost personalised medicine, the International Consortium of Personalized Medicine (ICPerMed) has recently published a consensus view on the research and development needed in order to further advance personalised medicine.

25/07/2016 Research and Science

ANR Partners’ Medimax Project Wins Bull-Joseph Fourier First Prize

The Medimax project has made use of supercomputing and modelling to speed up and enhance the way we visualise strokes. The two teams behind the project received this year’s Bull-Joseph Fourier First Prize, dedicated to accelerating the development of computer simulation.